Home > Annual Financials > KERALA AYURVEDA

KERALA AYURVEDA Financial Statement Analysis
[BOM: 530163]

The Revenues of KERALA AYURVEDA have increased by 29.45% YoY .
The Earnings Per Share (EPS) of KERALA AYURVEDA has decreased by Negative YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

KERALA AYURVEDA Last 5 Annual Financial Results
[BOM: 530163]

ConsolidatedMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹80 Cr₹62 Cr₹7,677,328 Cr₹62 Cr₹56 Cr
Expenses ₹71 Cr₹61 Cr₹6,941,478 Cr₹57 Cr₹48 Cr
Operating Profit (Excl OI) ₹9.53 Cr₹0.84 Cr₹735,850 Cr₹4.86 Cr₹8.07 Cr
Other Income ₹0.35 Cr₹0.11 Cr₹1,979 Cr₹0.51 Cr₹0.26 Cr
Interest ₹6.67 Cr₹6.41 Cr₹169,725 Cr₹2.57 Cr₹2.34 Cr
Depreciation ₹1.20 Cr₹1.28 Cr₹114,348 Cr₹0.98 Cr₹1.83 Cr
Profit Before Tax ₹2.81 Cr₹-6.74 Cr₹453,756 Cr₹3.10 Cr₹4.17 Cr
Profit After Tax ₹2.39 Cr₹-4.84 Cr₹405,330 Cr₹2.52 Cr₹2.88 Cr
Consolidated Net Profit ₹2.36 Cr₹-4.84 Cr₹389,733 Cr₹2.45 Cr₹2.81 Cr
Earnings Per Share (Rs)₹-0.51₹2.24₹-4.59₹3.69₹2.32
PAT Margin (%)-0.462.98-7.805.284.06
ROE(%)-14.76137.66-183.0393.9043.39
ROCE(%)6.2612.62-0.459.277.64
Total Debt/Equity(x)26.7422.60198.8913.0816.57

Key Financials

Market Cap : ₹ 327.4 Cr
Revenue (TTM) : ₹ 100.1 Cr
Net Profit(TTM) : ₹ -0.6 Cr
EPS (TTM) : ₹ -0.5
P/E (TTM) : -

Industry Peers & Returns1W1M1Y
KERALA AYURVEDA 1.1% -12.5% 210.5%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%


KERALA AYURVEDA Revenues
[BOM: 530163]

Y-o-Y

29.45 %

5 Yr CAGR

9.55 %

Years Revenues % Change
Mar2023 ₹80 Cr
29.45
Mar2022 ₹62 Cr
-100.00
Mar2021 ₹7,677,328 Cr
12,345,649.67
Mar2020 ₹62 Cr
11.46
Mar2019 ₹56 Cr -


KERALA AYURVEDA Operating Profit
[BOM: 530163]

Y-o-Y

1,034.40 %

5 Yr CAGR

4.24 %

Years Operating Profit % Change
Mar2023 ₹9.53 Cr
1,034.40
Mar2022 ₹0.84 Cr
-100.00
Mar2021 ₹735,850 Cr
15,128,391.78
Mar2020 ₹4.86 Cr
-39.73
Mar2019 ₹8.07 Cr -

Operating Margins
Y-o-Y

778.52 %

5 Yr CAGR

-4.85 %

Years Operating Margin% % Change
Mar2023 11.86%
778.52
Mar2022 1.35%
-85.91
Mar2021 9.58%
22.51
Mar2020 7.82%
-45.96
Mar2019 14.47% -

KERALA AYURVEDA Profit After Tax
[BOM: 530163]

Y-o-Y

Positive

5 Yr CAGR

-4.23 %

Years Profit After Tax % Change
Mar2023 ₹2.36 Cr
Positive
Mar2022 ₹-4.84 Cr
Negative
Mar2021 ₹389,733 Cr
15,939,897.14
Mar2020 ₹2.45 Cr
-12.93
Mar2019 ₹2.81 Cr -

PAT Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years PAT Margin(%) % Change
Mar2023 -0.46 %
Negative
Mar2022 2.98 %
Positive
Mar2021 -7.8 %
Negative
Mar2020 5.28 %
30.05
Mar2019 4.06 % -

KERALA AYURVEDA Earnings Per Share (EPS)
[BOM: 530163]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years EPS % Change
Mar2023 ₹-0.51
Negative
Mar2022 ₹2.24
Positive
Mar2021 ₹-4.59
Negative
Mar2020 ₹3.69
59.05
Mar2019 ₹2.32 -

KERALA AYURVEDA Return on Capital Employed (ROCE)
[BOM: 530163]

Y-o-Y

-50.40 %

5 Yr CAGR

-4.86 %

Years ROCE % Change
Mar2023 6.26%
-50.40
Mar2022 12.62%
Positive
Mar2021 -0.45%
Negative
Mar2020 9.27%
21.34
Mar2019 7.64% -

KERALA AYURVEDA Share Price vs Sensex

Current Share Price : ₹272.9
Current MarketCap: ₹ 327.4 Cr
Updated EOD on :Apr 19,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
KERALA AYURVEDA

1.1%

-12.5%

210.5%

SENSEX

-2.6%

-0%

21%

KERALA AYURVEDA related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about KERALA AYURVEDA Financials


How the annual revenues of KERALA AYURVEDA have changed ?

The Revenues of KERALA AYURVEDA have increased by 29.45% YoY .

How the Earnings per Share (EPS) of KERALA AYURVEDA have changed?

The Earnings Per Share (EPS) of KERALA AYURVEDA has decreased by Negative YoY .